What is the appropriate treatment for decreased libido in a male patient after a fistulotomy?

Treatment of Post-Fistulotomy Decreased Libido in Men

For men experiencing decreased libido after fistulotomy, measure morning total testosterone levels and if <300 ng/dL, initiate testosterone replacement therapy; if testosterone is normal, refer to a sexual health specialist for psychosexual counseling and consider PDE5 inhibitors if erectile dysfunction coexists. 1, 2

Initial Diagnostic Workup

The first step is determining whether the decreased libido has a hormonal basis:

• Measure total morning testosterone in all patients with decreased libido. If levels are <300 ng/dL, this indicates testosterone deficiency requiring treatment. 1, 2
• If testosterone is low, measure LH and prolactin to distinguish primary from secondary hypogonadism and rule out hyperprolactinemia, which universally causes reduced libido. 2
• Consider free testosterone or androgen index rather than total testosterone alone, as this prevents unnecessary investigation in up to 50% of men with low total testosterone. 2

A common pitfall is failing to recognize that pelvic surgery (including anal fistulotomy) can cause nerve damage affecting sexual function, similar to other pelvic procedures. 1

Treatment Algorithm Based on Testosterone Levels

If Testosterone <300 ng/dL:

Initiate testosterone replacement therapy using intramuscular, transdermal, or oral formulations. 1

• Testosterone therapy improves sexual desire and activity with clinically meaningful effect sizes (0.44-0.45) in men with low testosterone. 1
• Monitor for serious adverse effects including cardiovascular events, polycythemia, and hepatic dysfunction. 2
• Contraindications include: prostate cancer, severe heart failure, or untreated sleep apnea. 2

If Testosterone ≥300 ng/dL:

The decreased libido is likely multifactorial, requiring a comprehensive approach:

1. Refer to a sexual health specialist or psychotherapist as the primary intervention. 1, 2

• Psychosexual therapy shows 50-80% success rates and should be considered first-line for libido issues without hormonal deficiency. 2
• Psychotherapy helps patients reduce anxiety related to sexual situations and improves communication with partners. 1

2. Address coexisting erectile dysfunction if present:

• PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) are first-line pharmacologic treatment. 1
• These medications can also improve orgasmic problems (less intensity, difficulty achieving). 1
• Provide proper instructions on timing and dosing; titrate to maximum dose if needed. 1
• Contraindication: Do not use in patients taking oral nitrates due to dangerous blood pressure drops. 1

3. Consider medication review:

• SSRIs (paroxetine, sertraline, citalopram, fluoxetine) commonly cause reduced libido. 2
• Beta-blockers are strongly associated with sexual dysfunction; consider switching to ACE inhibitors or calcium channel blockers. 2
• 5-alpha reductase inhibitors (finasteride, dutasteride) can cause persistent sexual dysfunction. 2

Special Considerations for Post-Surgical Patients

While the evidence base specifically for fistulotomy is limited, extrapolating from other pelvic surgeries:

• Nerve damage from pelvic surgery can affect both erectile function and libido through neurovascular injury. 1
• Psychological factors including anxiety about recurrence, pain with sexual activity, and body image concerns are common after pelvic procedures. 1
• Partner involvement is crucial to therapeutic success; consider couples counseling when appropriate. 1

Treatment Monitoring

• Reassess at 3-6 months after initiating any intervention, as sexual function recovery can take 2-4 years in some post-surgical patients. 1
• If PDE5 inhibitors fail and testosterone is normal, second-line options include vacuum erection devices, intracavernosal injections, or intraurethral suppositories, managed in collaboration with a urologist. 1

Key Pitfalls to Avoid

• Do not assume libido issues are purely psychological without checking testosterone levels first. 2
• Do not overlook prolactin measurement if testosterone is low or libido loss is the primary complaint. 2
• Do not prescribe testosterone without ruling out contraindications, particularly prostate cancer. 2
• Do not delay referral to specialists when first-line interventions fail; early specialist involvement improves outcomes. 1